(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.23%) $83.66
(-1.16%) $1.619
(0.10%) $2 349.60
(-0.07%) $27.52
(0.25%) $924.40
(0.36%) $0.935
(0.67%) $11.02
(0.14%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments...
Stats | |
---|---|
Šios dienos apimtis | 269 605 |
Vidutinė apimtis | 554 921 |
Rinkos kapitalizacija | 995.42M |
EPS | £0 ( 2024-02-28 ) |
Last Dividend | £0.500 ( 2023-05-25 ) |
Next Dividend | £0 ( N/A ) |
P/E | 35.21 |
ATR14 | £0.289 (0.12%) |
Tūris Koreliacija
Spire Healthcare Group Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Spire Healthcare Group Koreliacija - Valiuta/Žaliavos
Spire Healthcare Group Finansinės ataskaitos
Annual | 2023 |
Pajamos: | £1.36B |
Bruto pelnas: | £520.60M (38.31 %) |
EPS: | £0.0676 |
FY | 2023 |
Pajamos: | £1.36B |
Bruto pelnas: | £520.60M (38.31 %) |
EPS: | £0.0676 |
FY | 2022 |
Pajamos: | £1.20B |
Bruto pelnas: | £440.50M (36.75 %) |
EPS: | £0.0214 |
FY | 2021 |
Pajamos: | £1.11B |
Bruto pelnas: | £491.20M (44.40 %) |
EPS: | £-0.0240 |
Financial Reports:
No articles found.
Spire Healthcare Group Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0.500 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | £1.800 | 2015-06-04 |
Last Dividend | £0.500 | 2023-05-25 |
Next Dividend | £0 | N/A |
Payout Date | 2023-06-23 | |
Next Payout Date | N/A | |
# dividends | 12 | -- |
Total Paid Out | £21.20 | -- |
Avg. Dividend % Per Year | 0.18% | -- |
Score | 2.58 | -- |
Div. Sustainability Score | 8.47 | |
Div.Growth Potential Score | 4.15 | |
Div. Directional Score | 6.31 | -- |
Year | Amount | Yield |
---|---|---|
2015 | £0 | 0.00% |
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £3.80 | 1.64% |
2019 | £3.80 | 3.44% |
2020 | £2.50 | 1.76% |
2021 | £0 | 0.00% |
2022 | £0 | 0.00% |
2023 | £0.500 | 0.22% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TPT.L | Dividend Knight | 2023-06-08 | Annually | 27 | 2.93% | |
MATE.L | Dividend Knight | 2023-06-29 | Quarterly | 7 | 2.31% | |
CRN.L | Dividend King | 2023-09-14 | Annually | 6 | 3.87% | |
RWS.L | Dividend Knight | 2023-06-22 | Semi-Annually | 21 | 1.50% | |
HMSO.L | Dividend Junior | 2023-08-24 | Annually | 32 | 1.96% | |
BBGI.L | Dividend Knight | 2023-09-07 | Semi-Annually | 13 | 2.94% | |
VSL.L | Dividend Knight | 2023-09-07 | Quarterly | 10 | 5.70% | |
MTVW.L | Dividend Knight | 2023-07-06 | Semi-Annually | 32 | 2.55% | |
DSCV.L | Dividend Knight | 2023-06-22 | Annually | 33 | 0.73% | |
SMDS.L | Dividend Knight | 2023-09-07 | Semi-Annually | 32 | 2.56% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0201 | 1.500 | 9.60 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0119 | 1.200 | 9.60 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0372 | 1.500 | -0.698 | -1.047 | [0.1 - 1] |
payoutRatioTTM | 0.0733 | -1.000 | 9.27 | -9.27 | [0 - 1] |
currentRatioTTM | 0.691 | 0.800 | -1.544 | -1.236 | [1 - 3] |
quickRatioTTM | 0.483 | 0.800 | -1.867 | -1.493 | [0.8 - 2.5] |
cashRatioTTM | 0.156 | 1.500 | -0.243 | -0.365 | [0.2 - 2] |
debtRatioTTM | 0.203 | -1.500 | 6.62 | -9.93 | [0 - 0.6] |
interestCoverageTTM | 1.360 | 1.000 | -0.607 | -0.607 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.495 | 2.00 | 9.83 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.286 | 2.00 | 9.86 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.627 | -1.500 | 7.49 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.383 | 1.000 | 6.95 | 6.95 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0931 | 1.000 | -0.138 | -0.138 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.431 | 1.000 | 8.72 | 8.72 | [0.2 - 2] |
assetTurnoverTTM | 0.594 | 0.800 | 9.37 | 7.50 | [0.5 - 2] |
Total Score | 8.47 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 36.44 | 1.000 | 6.42 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0372 | 2.50 | -0.449 | -1.047 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.286 | 2.00 | 9.90 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.203 | 1.500 | 4.93 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.495 | 2.00 | 9.83 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.0733 | 1.500 | 9.27 | -9.27 | [0 - 1] |
pegRatioTTM | -38.20 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.147 | 1.000 | 8.82 | 0 | [0.1 - 0.5] |
Total Score | 4.15 |
Spire Healthcare Group
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments. In addition, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory care, and rheumatology; and scans and investigations, skin treatments, spinal care, sports science, urology care, vascular surgery, weight loss, and women's health. Further, the company offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. It offers diagnostics, in-patient, daycase, and out-patient care services through 40 hospitals and eight clinics across England, Wales, and Scotland. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.